BASTA, a simple whole-blood assay for measuring β cell antigen-specific CD4+ T cell responses in type 1 diabetes.
Journal: Science translational medicine
Year: March 19, 2025
Endocrinologist
5
No OPD information available
Type 1 Diabetes (T1D)
Neurohypophyseal Diabetes Insipidus
Obesity
Type 2 Diabetes (T2D)
Abdominal Obesity Metabolic Syndrome
Diabetes Insipidus (DI)
Diabetic Ketoacidosis
Endoscopy
Metabolic Syndrome
John M. Wentworth is a male healthcare provider who helps people with different health issues like Type 1 Diabetes, Type 2 Diabetes, Obesity, and other metabolic conditions. He also specializes in treating specific conditions like Neurohypophyseal Diabetes Insipidus and Diabetic Ketoacidosis.
John M. Wentworth uses his skills and knowledge to diagnose and treat patients with care and expertise. He communicates with patients in a friendly and clear way, making them feel comfortable and confident in his care. Patients trust him because he listens to their concerns and explains things in a way they can understand.
To stay updated with the latest medical knowledge, John M. Wentworth regularly attends conferences, reads medical journals, and collaborates with other healthcare professionals. This helps him provide the best possible care for his patients.
John M. Wentworth works well with his colleagues and values teamwork in providing the best care for patients. He shares knowledge and expertise with other medical professionals to ensure that patients receive comprehensive and effective treatment.
Through his work, John M. Wentworth has positively impacted many patients' lives by helping them manage their health conditions and improve their overall well-being. His dedication and commitment to patient care have made a significant difference in the lives of those he treats.
One of John M. Wentworth's notable publications is "BASTA, a simple whole-blood assay for measuring β cell antigen-specific CD4+ T cell responses in type 1 diabetes." This publication shows his contributions to advancing medical knowledge in the field of diabetes research.
Additionally, John M. Wentworth has been involved in clinical trials like "A Phase 2, Randomised, Placebo Controlled Study Investigating the Efficacy of Baricitinib in New Onset Type 1 Diabetes Mellitus," which demonstrates his commitment to exploring new treatments and improving outcomes for patients.
Overall, John M. Wentworth is a dedicated healthcare provider who uses his expertise to help patients manage their health conditions and improve their quality of life.
Journal: Science translational medicine
Year: March 19, 2025
Enrollment Status: Completed
Published: December 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2
John M. Wentworth is an amazing Endocrinologist! He really took the time to listen to my concerns and provided clear explanations. Highly recommend!
Dr. Wentworth is a top-notch Endocrinologist in Melbourne. He is knowledgeable, caring, and truly dedicated to his patients' well-being. Excellent experience!
I had a great experience with Dr. Wentworth as my Endocrinologist. He is professional, kind, and helped me manage my condition effectively. Very satisfied!
John M. Wentworth is a fantastic Endocrinologist. He is thorough, compassionate, and I felt confident in his care. Highly recommend him to anyone in need of an Endocrinologist.
Dr. Wentworth is an exceptional Endocrinologist. He is attentive, knowledgeable, and truly cares about his patients' well-being. I am grateful for his expertise!
I highly recommend John M. Wentworth as an Endocrinologist. He is professional, understanding, and helped me improve my health significantly. Thank you, Dr. Wentworth!
Dr. Wentworth is a wonderful Endocrinologist. He is patient, thorough, and I felt comfortable discussing my health concerns with him. Excellent care!
I had a great experience with Dr. Wentworth as my Endocrinologist. He is knowledgeable, caring, and I felt well taken care of during my visits. Highly recommend him!